NMN: adverse events in a trial
A 12-week oral NMN trial in 30 healthy adults recorded adverse events in 8 of 15 NMN participants and 7 of 15 placebo participants, with none serious. Investigators attributed one brief episode of abdominal pain to NMN. The event totals do not mean that NMN caused every event. [1]
This small, short trial does not establish rare or lasting risks, safety by other routes, or safety of a particular laboratory reagent batch. [1]
What the studies reported
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Adverse events overall | 30 healthy adults, oral NMN for 12 weeks (15 in the NMN group, 15 on placebo) | Recorded in 8 of 15 NMN participants and 7 of 15 placebo participants; the event totals do not mean that NMN caused every event | [1] |
| Brief abdominal pain | The NMN group in the same trial | One episode, attributed to NMN by the investigators | [1] |
| Serious events | The same participants | None | [1] |